2022
TCT-164 Targeted Therapy With a Localized Abluminal Groove Low-Dose Sirolimus-Eluting Biodegradable-Polymer Coronary Stent: Subgroup Analysis of 5-Year Outcomes of the TARGET All Comers Randomized Trial
Kelbæk H, Lansky A, Xu B, Baumbach A, van Royen N, Knaapen P, Johnson T, Smits P, Vlachojannis G, Arkenbout K, Holmvang L, Janssens L, Ochala A, Wijns W. TCT-164 Targeted Therapy With a Localized Abluminal Groove Low-Dose Sirolimus-Eluting Biodegradable-Polymer Coronary Stent: Subgroup Analysis of 5-Year Outcomes of the TARGET All Comers Randomized Trial. Journal Of The American College Of Cardiology 2022, 80: b66. DOI: 10.1016/j.jacc.2022.08.193.Peer-Reviewed Original Research
2011
Performance of everolimus-eluting and paclitaxel-eluting coronary stents in women: 2-year outcomes from the SPIRIT IV trial
Lansky A, Yaqub M, Sood P, Ying S, Wang J, Caputo R, Farhat N, Applegate R, Skelding K, Kereiakes D, Sudhir K, Stone G. Performance of everolimus-eluting and paclitaxel-eluting coronary stents in women: 2-year outcomes from the SPIRIT IV trial. Cardiovascular Revascularization Medicine 2011, 12: e9. DOI: 10.1016/j.carrev.2011.04.267.Peer-Reviewed Original Research
2010
One-year outcomes of everolimus-eluting and paclitaxel-eluting coronary stents in women: analysis from the Spirit IV Trial
Lansky A, Wang J, Kereiakes D, Sood P, Yaqub M, Shih-Wa Y, Simonton C, Caputo R, Applegate R, Stone G. One-year outcomes of everolimus-eluting and paclitaxel-eluting coronary stents in women: analysis from the Spirit IV Trial. Cardiovascular Revascularization Medicine 2010, 11: 277-278. DOI: 10.1016/j.carrev.2010.03.029.Peer-Reviewed Original ResearchComparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.
Applegate RJ, Hermiller JJ, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky AJ, Sudhir K, Stone GW. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention 2010, 6: 437-46. PMID: 20884430, DOI: 10.4244/eij30v6i4a75.Peer-Reviewed Original ResearchConceptsPaclitaxel-eluting stentsClinical outcomesStent typeMajor adverse cardiac eventsTwo-year event ratesSPIRIT IIIPaclitaxel-eluting coronary stentsSPIRIT III trialYear clinical outcomesAdverse cardiac eventsCardiac eventsIII trialsPE groupTwo-vesselPatientsEvent ratesCoronary stentsTrialsVessel treatmentStentsOutcomesVesselsSignificant interactionStentingLesionsCOMPARISON OF EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING CORONARY STENTS IN PATIENTS UNDERGOING MULTI-VESSEL STENTING: POOLED ANALYSIS FROM THE SPIRIT III AND SPIRIT IV RANDOMIZED TRIALS
Kereiakes D, Sudhir K, Hermiller J, Lansky A, Doostzadeh J, Pierson W, Su X, Gordon P, Stone G. COMPARISON OF EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING CORONARY STENTS IN PATIENTS UNDERGOING MULTI-VESSEL STENTING: POOLED ANALYSIS FROM THE SPIRIT III AND SPIRIT IV RANDOMIZED TRIALS. Journal Of The American College Of Cardiology 2010, 55: a140.e1317. DOI: 10.1016/s0735-1097(10)61318-6.Peer-Reviewed Original Research
2003
Usefulness of a cobalt chromium coronary stent alloy
Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, Leon MB, Fink S, Marin L, Lansky AJ, Investigators G. Usefulness of a cobalt chromium coronary stent alloy. The American Journal Of Cardiology 2003, 92: 463-466. PMID: 12914881, DOI: 10.1016/s0002-9149(03)00669-6.Peer-Reviewed Original Research
2000
Evolving trends in interventional device use and outcomes: Results from the National Cardiovascular Network database
Peterson E, Lansky A, Anstrom K, Muhlbaier L, Popma J, Satler L, Lanzilotta M, Network F. Evolving trends in interventional device use and outcomes: Results from the National Cardiovascular Network database. American Heart Journal 2000, 139: 198-207. PMID: 10650291, DOI: 10.1016/s0002-8703(00)90226-6.Peer-Reviewed Original ResearchConceptsComplication rateCoronary anatomyAtherectomy devicesInterventional strategiesClinical practiceNew coronary interventional devicesCoronary stentsCoronary interventional devicesCoronary stent usePatient's coronary anatomyPercutaneous interventional strategyPostprocedure hospital stayProcedural success rateOverall mortality rateGeneral clinical practiceNew interventional strategiesDevice usePercentage of casesRotational atherectomy deviceInterventional databasePostprocedure lengthHospital stayCoronary interventionDirectional atherectomyPatient characteristics
1997
Early and late assessment of the Micro Stent PL coronary stent for restenosis and suboptimal balloon angioplasty
Webb J, Popma J, Lansky A, Carere R, Rabinowitz A, Singer J, Dodek A. Early and late assessment of the Micro Stent PL coronary stent for restenosis and suboptimal balloon angioplasty. American Heart Journal 1997, 133: 369-374. PMID: 9060809, DOI: 10.1016/s0002-8703(97)70235-7.Peer-Reviewed Original ResearchConceptsBalloon angioplastyStent dislodgmentCoronary stentsManagement of dissectionMinimal lumen diameterSuboptimal balloon angioplastySite of placementAdditional patientsDistal deliveryProspective studyStent thrombosisDiameter stenosisBalloon catheterLate lossProcedural failurePatientsSix monthsLumen diameterStentsRestenosisInitial assessmentLater assessmentsAngioplastyStainless steel stentsFuture stent designs